Huttunen J, Taiminen T, Kähkönen J, Tuominen K, Salokangas R K
Department of Psychiatry, Turku University Central Hospital, Finland.
Acta Psychiatr Scand. 1999 Mar;99(3):220-2. doi: 10.1111/j.1600-0447.1999.tb00979.x.
To explore the applicability of the Depression Scale (DEPS), a screening instrument for detecting depression in primary health care, in schizophrenia.
The DEPS was compared with the Calgary Depression Scale (CDS) among 63 patients with schizophrenia.
Using the CDS as a gold standard, the positive and negative predictive values of the DEPS for the diagnosis of depression were 41% and 97%, respectively. The correlation between the total CDS scores and the total DEPS scores was 0.73.
The DEPS appears to be useful for screening depression among schizophrenic patients, but the positive diagnosis must be confirmed with a clinical interview.
探讨初级卫生保健中用于检测抑郁症的筛查工具——抑郁量表（DEPS）在精神分裂症中的适用性。
在63例精神分裂症患者中，将DEPS与卡尔加里抑郁量表（CDS）进行比较。
以CDS作为金标准，DEPS诊断抑郁症的阳性预测值和阴性预测值分别为41%和97%。CDS总分与DEPS总分之间的相关性为0.73。
DEPS似乎有助于筛查精神分裂症患者中的抑郁症，但阳性诊断必须通过临床访谈来确认。
